Anxiolytics: Past, present, and future agents

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations


Although anxiety disorders were classified as neurotic disorders and not systematically studied before DSM-III, researchers and clinicians have been searching for effective, safe agents to treat anxiety symptoms and disorders for over a century. In that time, barbiturates, benzodiazepines, and many classes of antidepressants have been used as anxiolytics, all with side effect profiles that made them less than optimal treatments for anxiety. The recognition of the role of GABA in anxiety disorders has led researchers to develop anxiolytics that target GABA. The long-sought-after class of anxiolytics that are both effective and safe may be found in the new research being conducted with agents that selectively target GABA receptors and their subtypes.

Original languageEnglish (US)
Pages (from-to)3-6
Number of pages4
JournalJournal of Clinical Psychiatry
Issue numberSUPPL. 3
StatePublished - Apr 12 2003
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Anxiolytics: Past, present, and future agents'. Together they form a unique fingerprint.

Cite this